Continuous Positive Airway Pressure Reduces Plasma Neurochemical Levels in Patients with OSA: A Pilot Study

Obstructive sleep apnea (OSA) is a risk factor for neurodegenerative diseases. This study determined whether continuous positive airway pressure (CPAP), which can alleviate OSA symptoms, can reduce neurochemical biomarker levels. Thirty patients with OSA and normal cognitive function were recruited...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Wen-Te Liu, Huei-Tyng Huang, Hsin-Yi Hung, Shang-Yang Lin, Wen-Hua Hsu, Fang-Yu Lee, Yi-Chun Kuan, Yin-Tzu Lin, Chia-Rung Hsu, Marc Stettler, Chien-Ming Yang, Jieni Wang, Ping-Jung Duh, Kang-Yun Lee, Dean Wu, Hsin-Chien Lee, Jiunn-Horng Kang, Szu-Szu Lee, Hsiu-Jui Wong, Cheng-Yu Tsai, Arnab Majumdar
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2023-02-01
coleção:	Life
Assuntos:	obstructive sleep apnea (OSA) neurodegenerative diseases continuous positive airway pressure (CPAP) total tau (T-Tau) amyloid beta-peptide 42 (Aβ<sub>42</sub>)
Acesso em linha:	https://www.mdpi.com/2075-1729/13/3/613
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!